Guidance for stem cell therapy for juvenile systemic sclerosis patients
Year: 2024
Type: conference-paper
Abstract: Introduction: Hemopoetic stem cell transplantation (HSTC) and cellular therapies (CT) are a promising therapeutic options for adult and for juvenile systemic sclerosis (jSSc) patients. Currently, studies regarding efficacy of this procedure are derived mostly from adult patients. As pediatric patients [for full text, please go to the a.m. URL]
DOI: 10.3205/24dgrh126
Authors: Foeldvari, Ivan, Torok, Kathryn, Silva, Juliana, Horvei, Paulina, Denton, Christopher P., Roser, Franziska, Constantin, Tamas, Costa Reis, Patricia, Curran, Megan, Cutolo, Maurizio, Henes, Jörg, Hinrichs, Bernd, Fligelstone, Kim, Li, Suzanne, Maillard, Susan, Moinzadeh, Pia, Orteu, Catherine, Pain, Clare, Pilkington, Clarissa, Schraven, Linda, Smith, Vanessa
Institutions: University of Pittsburgh, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Great Ormond Street Hospital, Royal Free London NHS Foundation Trust, Semmelweis University, University of Lisbon, Children's Hospital Colorado, Ospedale Policlinico San Martino, University of Genoa, Asklepios, Asklepios Kliniken Hamburg, Hackensack University Medical Center, University Hospital Cologne, Alder Hey Children's NHS Foundation Trust, Alder Hey Children's Hospital, Ghent University
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6965520103
FWCI:
Cites:
Cited by:
Related to: